We are live on
!
Find out more
Primecap Management Portfolio holdings
AUM
$169B
Turnover
4.85%
1-Year Est. Return
114.72%
This Fund
S&P 500
This Quarter
Est. Return
-1.54%
1 Year Est. Return
+114.72%
3 Year Est. Return
+234.44%
5 Year Est. Return
+291.25%
10 Year Est. Return
+1,263.36%
AUM
$96.4B
AUM Growth
-$1.4B
(-1.4%)
Cap. Flow
+$1.2B
Cap. Flow
% of AUM
1.25%
Top 10 Holdings %
Top 10 Hldgs %
33.93%
Holding
280
New
10
Increased
138
Reduced
66
Closed
10
Avg Time Held
2.2
years
Top 10 Avg Time Held
2.4
years
Top 20 Avg Time Held
1.9
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AstraZeneca
AZN
|
+$363M |
| 2 |
JPMorgan Chase
JPM
|
+$363M |
| 3 |
American Airlines Group
AAL
|
+$310M |
| 4 |
CarMax
KMX
|
+$258M |
| 5 |
FedEx
FDX
|
+$191M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Johnson & Johnson
JNJ
|
+$779M |
| 2 |
DYAX
DYAX CORPORATION
DYAX
|
+$394M |
| 3 |
BRCM
BROADCOM CORP CL-A
BRCM
|
+$213M |
| 4 |
Bath & Body Works
BBWI
|
+$134M |
| 5 |
GSK
GSK
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.64% |
| 2 | Healthcare | 23.8% |
| 3 | Industrials | 15.3% |
| 4 | Consumer Discretionary | 9.55% |
| 5 | Financials | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
126
Stratasys
SSYS
$624M
| $104M | 0.11% |
4,006,200
+721,200
| +22% | +$14.7M |
2013 Q2
11 quarters
|
|
127
Sanofi
SNY
$96.5B
| $102M | 0.11% |
2,549,382
-218,200
| -8% | -$8.77M |
2013 Q2
11 quarters
|
|
128
DELISTED
Sprint Corporation
S
| $101M | 0.1% |
28,890,500
+1,240,500
| +4% | +$3.96M |
2014 Q3
6 quarters
|
|
129
Descartes Systems
DSGX
$7.58B
| $97M | 0.1% |
4,971,090
| – | – |
2013 Q2
11 quarters
|
|
|
VMW
130
DELISTED
VMware, Inc
VMW
| $93.1M | 0.1% |
1,780,187
+278,643
| +19% | +$13.8M |
2013 Q2
11 quarters
|
|
131
Gildan
GIL
$7.78B
| $92.9M | 0.1% |
3,043,300
-538,400
| -15% | -$14.3M |
2014 Q2
7 quarters
|
|
132
Charles River Laboratories
CRL
$14.6B
| $92.1M | 0.1% |
1,213,160
-58,222
| -5% | -$4.31M |
2013 Q2
11 quarters
|
|
133
Waters Corp
WAT
$43.6B
| $85.9M | 0.09% |
650,867
-250
| -0% | -$31.2K |
2013 Q2
11 quarters
|
|
134
VF Corp
VFC
$6.68B
| $82.4M | 0.09% |
1,351,501
+33,984
| +3% | +$1.97M |
2013 Q2
11 quarters
|
|
135
Celanese
CE
$5.1B
| $80.6M | 0.08% |
1,230,800
| – | – |
2013 Q2
11 quarters
|
|
|
CPHD
136
DELISTED
Cepheid Inc
CPHD
| $80.3M | 0.08% |
2,407,500
+100
| +0% | +$3.14K |
2013 Q2
11 quarters
|
|
137
Jabil
JBL
$30.1B
| $79.5M | 0.08% |
4,125,875
+35,925
| +0.9% | +$725K |
2013 Q2
11 quarters
|
|
|
NBL
138
DELISTED
Noble Energy, Inc.
NBL
| $79.3M | 0.08% |
2,523,800
-125,000
| -5% | -$3.82M |
2013 Q2
11 quarters
|
|
139
DuPont de Nemours
DD
$17.8B
| $79.1M | 0.08% |
614,011
+11,758
| +2% | +$1.41M |
2013 Q2
11 quarters
|
|
|
EPZM
140
DELISTED
Epizyme, Inc
EPZM
| $79M | 0.08% |
6,518,627
+1,273,000
| +24% | +$12.9M |
2013 Q2
11 quarters
|
|
141
Magnite
MGNI
$3.51B
| $79M | 0.08% |
4,321,300
+1,924,400
| +80% | +$29.5M |
2015 Q2
3 quarters
|
|
142
F5
FFIV
$25.9B
| $76.1M | 0.08% |
718,550
-38,950
| -5% | -$3.73M |
2013 Q2
11 quarters
|
|
143
Entegris
ENTG
$22.4B
| $71.4M | 0.07% |
5,240,850
+14,200
| +0.3% | +$172K |
2013 Q2
11 quarters
|
|
|
TWC
144
DELISTED
TIME WARNER CABLE INC NEW COM STK
TWC
| $71.2M | 0.07% |
348,004
| – | – |
2013 Q2
11 quarters
|
|
145
ExxonMobil
XOM
$718B
| $66M | 0.07% |
789,212
| – | – |
2013 Q2
11 quarters
|
|
146
Universal Display
OLED
$3.6B
| $65.3M | 0.07% |
1,207,875
+16,800
| +1% | +$821K |
2014 Q3
6 quarters
|
|
|
CRAY
147
DELISTED
Cray, Inc.
CRAY
| $64.3M | 0.07% |
1,534,750
-564,775
| -27% | -$21.5M |
2014 Q3
6 quarters
|
|
148
Xencor
XNCR
$1.78B
| $63.5M | 0.07% |
4,731,995
+1,115,081
| +31% | +$13.2M |
2013 Q4
9 quarters
|
|
149
DELISTED
Coterra Energy
CTRA
| $61.8M | 0.06% |
2,723,400
-10,000
| -0.4% | -$201K |
2013 Q2
11 quarters
|
|
150
FormFactor
FORM
$8.85B
| $60.6M | 0.06% |
8,336,959
+114,041
| +1% | +$866K |
2013 Q2
11 quarters
|
|
Similar funds
Primecap Management's Q1 2016 Portfolio in Review
As of Q1 2016, Primecap Management held 280 positions worth $96.4B, down 1.4% from $97.8B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Primecap Management's Q1 2016 filing shows 10 new, 138 increased, 66 reduced and 10 closed positions. Its largest new stake was Northern Trust: 1,775,400 shares worth $116M. The largest sale was Johnson & Johnson, an estimated $779M.
By sector, the portfolio is most concentrated in Technology at 29% of assets, up from 27% a quarter earlier, followed by Healthcare and Industrials.
- Primecap Management's largest Q1 2016 buy was Northern Trust: 1,775,400 shares worth $116M.
- Primecap Management added most to AstraZeneca in Q1 2016, an estimated $363M increase.
- Primecap Management's biggest Q1 2016 reduction was Johnson & Johnson, cutting an estimated $779M.
- Primecap Management fully exited DYAX CORPORATION in Q1 2016, selling an estimated $394M.
- Primecap Management's ten largest holdings make up 34% of its $96.4B portfolio in Q1 2016.
- Primecap Management opened 10 new positions and closed 10 in Q1 2016.
- Primecap Management's portfolio value fell 1.4% quarter-over-quarter to $96.4B.
Based on Primecap Management's 13F filing for Q1 2016, filed 12 May 2016.